Vor Biopharma
VOR
VOR
71 hedge funds and large institutions have $54.5M invested in Vor Biopharma in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
+2
Holders Change %
+2.9%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
23
Increased
18
Reduced
19
Closed
21
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
-$21K
Top Buyers
| 1 |
Goldman Sachs
New York
|
$375K |
| 2 |
Millennium Management
New York
|
$390K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$247K |
| 4 |
Jane Street
New York
|
$223K |
| 5 |
Renaissance Technologies
New York
|
$495K |
